Jason After graduating from Cornell, Jason has 20 years experience in biotech R&D. He has led development and evolution of enzymes including SuperScript III and other reverse transcriptase and polymerases at Invitrogen/Life Technologies. He has led groups focusing on synthetic genes and error correction. He now leads the Synthetic Biology Enzymology R&D team in the Life Sciences Solutions Group of Thermo Fisher Scientific in Carlsbad, CA. His group is focused on developing and improving tools for genome editing using the TAL and CRISPR technologies.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)